RSWM
ANVS icon

Robertson Stephens Wealth Management’s Annovis Bio ANVS Stock Holding History

Robertson Stephens Wealth Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.6K Hold
18,579
– – ﹤0.01% 640
2026
Q1 		$41.4K Hold
18,579
– – ﹤0.01% 607
2025
Q4 		$64.3K Buy
+18,579
New +$55.8K ﹤0.01% 630

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Robertson Stephens Wealth Management's ANVS Position: Q2 2026 in Review

Robertson Stephens Wealth Management held its Annovis Bio (ANVS) position steady in Q2 2026 at 18,579 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Robertson Stephens Wealth Management first reported a position in ANVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $64.3K in Q4 2025. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Robertson Stephens Wealth Management held 18,579 shares of Annovis Bio worth $34.6K as of Q2 2026.
  • Robertson Stephens Wealth Management left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up ﹤0.01% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #640 holding.
  • Robertson Stephens Wealth Management first reported a position in Annovis Bio in Q4 2025 and has held it in 3 quarters since.
  • Robertson Stephens Wealth Management's Annovis Bio position peaked at $64.3K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.